Skip to main content

Advertisement

Table 2 Summary of the mercury in urine and plasma values at screening, day 15 and day 45

From: Efficacy of N,N‘bis-(2-mercaptoethyl) isophthalamide on mercury intoxication: a randomized controlled trial

  NBMI 300 mg (n = 11) NBMI 100 mg (n = 13) Placebo (n = 12)
Mercury in urine [μg/l]a   
 Screening 26.5 (4.22–321.0) 39.1 (12.6–160.0) 9.16 (1.7–230.0)
 Day 15 18.5 (2.1–131) 37.7 (8.1–132.0) 13.9 (1.3–161.0)
 Day 45 14.2 (1.8–226.0) 39.1 (2.6–96.1) 11.3 (1.3–275.0)
Mercury in urine [μg/g creatinine]a   
 Screening 62.4 (7.6–773.2) 66.7 (12.4–200) 18.7 (2.6–488.5)
 Day 15 65.2 (2.6–298.0) 64.4 (17.2–241.0) 29.75 (1.8–536.7)
 Day 45 34.8 (2.9–1883.3) 53.3 (13.2–340.2) 9.86 (0.4–1797.4)
Mercury in plasma [μg/l]a   
 Screening 5.8 (1.3–95.9) 6.4 (1.7–25.8) 6.1 (1.4–45.8)
 Day 15 6.8 (1.7–64.4) 8.0 (2.6–33.6) 5.1 (1.5–42.9)
 Day 45 6.4 (1.8–49.0) 9.3 (1.6–42.2) 5.9 (1.0–90.1)
  1. aShown values are medians. Range is shown in brackets